Presented by: Prem Premsrirut, Mirimus, Inc.
About Episode 1
In this episode, Prem shares how she built a leading RNAi and CRISPR/Cas9 modeling technology through spinning out and securing funding from several types of investors.
About Prem Premsrirut
Prem founded and has served as President and CEO of Mirimus, Inc. since 2010. Mirimus specializes in developing platform technology for genetic manipulation of animal models of human disease and therapeutic modeling for drug discovery research. Their work accelerates pipelines of bench to bedside discoveries using RNA interference and CRISPR/Cas gene editing technologies. Dr. Premsrirut was an MD/PhD Medical Scientist fellow at the SUNY Stony Brook School of Medicine and Cold Spring Harbor Laboratory.
Complete the form to the right for access to episode 1 of the Charles River Innovator's Series.